Combination of targeted daunorubicin liposomes and targeted emodin liposomes for treatment of invasive breast cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Combination of targeted daunorubicin liposomes and targeted emodin liposomes for treatment of invasive breast cancer

Published:2019-09-02 Issue:3 Volume:28 Page:245-258
ISSN:1061-186X
Container-title:Journal of Drug Targeting
language:en
Short-container-title:Journal of Drug Targeting

Author:

Fu Min¹,Tang Wei²,Liu Jing-Jing¹,Gong Xiao-Qing³,Kong Liang¹,Yao Xue-Min¹,Jing Ming¹,Cai Fu-Yi¹,Li Xue-Tao¹,Ju Rui-Jun³

Affiliation:

1. School of Pharmacy, Liaoning University of Traditional Chinese Medicine, Dalian, China;

2. Linyi Food and Drug Testing Center, Linyi, China;

3. Department of Pharmaceutical Engineering, Beijing Institute of Petrochemical Technology, Beijing, China

Publisher

Informa UK Limited

Subject

Pharmaceutical Science

Link

https://www.tandfonline.com/doi/pdf/10.1080/1061186X.2019.1656725

Reference43 articles.

1. Breast Cancer: Current Developments in Molecular Approaches to Diagnosis and Treatment

2. Epirubicin-loaded polymeric micelles effectively treat axillary lymph nodes metastasis of breast cancer through selective accumulation and pH-triggered drug release

3. Theory and practice of clinical pharmacodynamics in oncology drug development

4. Breast cancer in reproductive age. The new plaque or just myth?

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and efficacy evaluation of nanoliposomes targeting CAFs-LCSCs communication for hepatocellular carcinoma treatment;Chemical Engineering Journal;2024-09

2. Non-Coding RNAs and Estrogen Receptor Signaling in Breast Cancer: Nanotechnology-Based Therapeutic Approaches;Pathology - Research and Practice;2024-08

3. Liposomal Nano-Based Drug Delivery Systems for Breast Cancer Therapy: Recent Advances and Progresses;Anti-Cancer Agents in Medicinal Chemistry;2024-07

4. Liposomes in the cosmetics: present and outlook;Journal of Liposome Research;2024-05-07

5. Polymer lipid hybrid nanoparticles encapsulated with Emodin combined with DOX reverse multidrug resistance of breast cancer via IL-6/JAK2/STAT3 signaling pathway;Cancer Nanotechnology;2024-01-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3